BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,482,000 | -40.3% | 3,703,991 | -17.8% | 0.26% | -42.3% |
| Q2 2022 | $9,188,000 | -25.5% | 4,503,991 | 0.0% | 0.45% | -30.6% |
| Q1 2022 | $12,341,000 | -44.1% | 4,503,991 | 0.0% | 0.65% | -37.7% |
| Q4 2021 | $22,070,000 | -61.3% | 4,503,991 | 0.0% | 1.04% | -64.5% |
| Q3 2021 | $56,975,000 | -18.2% | 4,503,991 | 0.0% | 2.95% | -4.6% |
| Q2 2021 | $69,632,000 | -53.0% | 4,503,991 | 0.0% | 3.09% | -49.5% |
| Q1 2021 | $148,226,000 | – | 4,503,991 | – | 6.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |